Boston Scientific (BSX) Tops Q1 EPS by 5c; Guides Above Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.32 +5.57%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.56, $0.05 better than the analyst estimate of $0.51. Revenue for the quarter came in at $3.86 billion versus the consensus estimate of $3.68 billion.
GUIDANCE:
Boston Scientific sees Q2 2024 EPS of $0.57-$0.59, versus the consensus of $0.56.
Boston Scientific sees FY2024 EPS of $2.29-$2.34, versus the consensus of $2.25.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Cabot Corp. (CBT) Tops Q4 EPS by 7c, Beats on Revenue; Offers FY EPS Guidance
- National Presto Indust. (NPK) Reports Q3 EPS of $2.79
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
